The Discounted Cash Flow (DCF) valuation of Moderna Inc (MRNA) is (117.04) USD. With the latest stock price at 31.58 USD, the upside of Moderna Inc based on DCF is -470.6%.
Based on the latest price of 31.58 USD and our DCF valuation, Moderna Inc (MRNA) is a sell. selling MRNA stocks now will result in a potential gain of 470.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.9% | 8.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (253.00) - (77.27) | (117.04) |
| Upside | -901.1% - -344.7% | -470.6% |